Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-30

Clinical Trial Update: Defining Remission With Etanercept in AS in Real Life Clinical Practice

View source ↗

Summary

An update on defining remission with etanercept in real-life practice for ankylosing spondylitis, based on completed clinical trial data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Ankylosing Spondylitis | Status: COMPLETED | Results posted: 2018-11-30